The price for a 5-day course of the antiviral drug remdesivir—which has shown to reduce hospital stays for patients with severe COVID-19 illness—is $2,340. This cost is less than the $5,080 price tag recommended by the Institute for…
Some dental implants fail. While many ideas concerning the genesis of this failure have been proposed, at present, most would argue that bacteria are strongly associated with peri-implant disease and implant loss. Numerous secondary factors…
The World Health Organization states that AstraZeneca’s COVID-19 vaccine is leading the pack, with Moderna’s version a close second. Developed at Britain’s Oxford University, the AstraZeneca vaccine is already undergoing human trials. The…
A survey was developed to evaluate the attitudes and willingness of general and specialty dentists to treat people with special needs and to identify the barriers to greater participation by dentists in the care of these patients. Overall,…
As case numbers spike across the Sun Belt, the United States Centers for Disease Control and Prevention (CDC) has added to the list of those populations who are at high risk of COVID-19. First, the age threshold that initially listed adults…
The Small Business Personal Protective Equipment (PPE) Tax Credit Act HR 7216 has been introduced by a bipartisan coalition to provide small businesses with a $25,000 tax credit for purchasing the PPE required to reopen. The bill—sponsored…
A study led by researchers at the University of Birmingham in the United Kingdom suggests oral health professionals play a vital part in identifying people at high risk of developing pre-diabetes and type 2 diabetes.
While the United States struggles to contain the COVID-19 pandemic, dentistry continues its recovery, according to a new poll by the American Dental Association Health Policy Institute. Taken during the week of June 15, the poll shows that…